Prevalence of self-reported prediabetes among adults participating in a community-based health awareness program, New York State

Preventing Chronic Disease

Volumn 6, Issue 2, 2009, Pages

  Hosler, Akiko S ^a  

^a UNIVERSITY AT ALBANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; COMMUNITY CARE; FEMALE; HEALTH CARE DELIVERY; HEALTH INSURANCE; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INFORMATION PROCESSING; MALE; MIDDLE AGED; PREVALENCE; RACE; STATISTICAL MODEL; UNITED STATES;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; COMMUNITY HEALTH SERVICES; CONTINENTAL POPULATION GROUPS; DATA COLLECTION; FEMALE; HEALTH SERVICES ACCESSIBILITY; HUMANS; INSURANCE, HEALTH; LOGISTIC MODELS; MALE; MIDDLE AGED; NEW YORK; PREDIABETIC STATE; PREVALENCE; YOUNG ADULT;

EID: 66449089495     PISSN: 15451151     EISSN: 21665435     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. National diabetes fact sheet: general information and national estimates on diabetes in the United States, 2005. Atlanta (GA): Centers for Disease Control and Prevention; 2005.
2. Hogan P, Dall T, Nikolov P, for American Diabetes Association. Economic costs of diabetes in the US in 2002. Diabetes Care 2003;26(3):917-32.
3. Gregg EW, Cadwell BL, Cheng YJ, Cowie CC, Williams DE, Geiss LS, et al. Trends in the prevalence and ratio of diagnosed to undiagnosed diabetes according to obesity levels in the US. Diabetes Care 2005;27(12):2806-12.
4. Boyle JP, Honeycutt AA, Narayan KMV, Hoerger TJ, Geiss LS, Chen H, et al. Projection of diabetes burden through 2050: impact of changing demography and disease prevalence in the US. Diabetes Care 2001;24(11):1936-40.
5. Diabetes: disabling disease to double by 2050, at a glance 2007. Atlanta (GA): Centers for Disease Control and Prevention; 2007.
6. Narayan KMV, Imperatore G, Benjamin SM, Engelgau MM. Targeting people with pre-diabetes: lifestyle interventions should also be aimed at people with pre-diabetes. BMJ 2002;325:403-4.
7. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2008;31(7361):S55-60.
8. de Vegt F, Dekker JM, Jager A, Hienkens E, Kostense PJ, Stehouwer CDA, et al. Relation of impaired fasting and postload glucose with incident type 2 in a Dutch population: the Hoorn study. JAMA 2001;285(16):2109-13.
9. Coutinho M, Gerstein HC, Wang Y, Yusuf S. The relationship between glucose and incident cardiovascular events: a metaregression analysis of published data from 20 studies of 95, 783 people followed for 12.4 years. Diabetes Care 1999;22(8):233-40.
10. Meigs JB, Nathan DM, D'Agostino RB, Wilson PW. Framingham Offspring Study: fasting and postchallenge glycemia and cardiovascular disease risk. Diabetes Care 2002;25(10):1845-50.
11. Chiasson JL, Josse RG, Gomis R, Hanefeld M, Karasik A, Laakso M, for the STOP-NIDDM Trial Research Group. Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial. Lancet 2002;359(9323):2072-77.
12. Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002;346(6):393-403.
13. Eriksson KF, Lindgarde F. Prevention of type 2 (non-insulin-dependent) diabetes mellitus by diet and physical exercise: the 6-year Malmo feasibility study. Diabetologia 1991;34(12):891-8.
14. Pan XR, Li GW, Hu YH, Wang JX, Yang WY, An ZX, et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance: the Da Qing IGT and Diabetes Study. Diabetes Care 1997;20(4):537-44.
15. Tuomilehto J, Lindstorm J, Eriksson JG, Valle TT, Hamalainrin H, Ilanne-Parikka P, et al for the Finnish Diabetes Prevention Study Group. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001;344(18):1343-50.
16. Diabetes Prevention Program Research Group. The Diabetes Prevention Program: design and methods for a clinical trial in the prevention of type 2 diabetes. Diabetes Care 1999;22(4):623-4.
17. American Diabetes Association and National Institute of Diabetes, Digestive and Kidney Diseases. The prevention or delay of type 2 diabetes. Diabetes Care 2002;25(4):742-9. Erratum in: Diabetes Care 2002;25(5):947.
18. Engelgau MM, Narayan KMV, Herman WH. Screening for type 2 diabetes. Diabetes Care 2000;23(10):1563-80. Review. Erratum in: Diabetes Care 2000;23(12):1868-9.
19. US Preventive Services Task Force. Guide to clinical preventive services. 2nd ed. Alexandria, VA: International Medical Publishing; 1996.
20. Cowie CC, Rust KF, Byrd-Holt DD, Eberhardt MS, Flegal KM, Engelgau MM, et al. Prevalence of diabetes and impaired fasting glucose in adults in the US population: National Health and Nutrition Examination Survey 1999-2002. Diabetes Care 2006;29(6):1263-8.
21. Williams DE, Cadwell BL, Cheng YJ, Cowie CC, Gregg EW, Geiss LS, et al. Prevalence of impaired fasting glucose and its relationship with cardiovascular disease risk factors in US adolescents, 1999-2000. Pediatrics 2005;116(5):1122-6.
22. Behavioral Risk Factor Surveillance System Survey Questionnaire. Atlanta (GA): Centers for Disease Control and Prevention; 2003-2007.
23. Behavioral Risk Factor Surveillance System Prevalence Data: Diabetes 2006. Atlanta (GA): Centers for Disease Control and Prevention; 2007.
24. National Diabetes Information Clearinghouse. Insulin resistance and pre-diabetes. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases, National Institute of Health; 2003.
25. National Diabetes Education Program. Small Steps. Big Rewards: Your Game Plan to Prevent Type 2 Diabetes. Washington (DC): National Diabetes Education Program, US Department of Health and Human Services (NIH Publication No. 06-5334); 2006.
26. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 2003;26(11):3160-7.
27. Hosler AS, Berberian EL, Spence MM, Hoffman DP. Outcome and cost of statewide diabetes screening and awareness initiative in New York State. J Public Health Manag Pract 2005;11(1):59-64.
28. Burt CW, McCraig LF, Rochtsteiner EA. Ambulatory medical care utilization estimates for 2005. Adv Data 2007;29(388):1-15.
29. Gohdes D. Diabetes in North American Indians and Alaskan Natives. In: National Diabetes Data Group. Diabetes in America. 2nd ed. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, NIH Publication No. 95-1468; 1995. p. 683-701.
30. Indian Health Services Division of Diabetes Treatment and Prevention and Area Diabetes Consultants. HIS Guidelines for Care of Adults with Prediabetes and/or the Metabolic Syndrome in Clinical Settings. Washington (DC): Indian Health Service; 2005.
31. Benjamin SM, Valdez R, Geiss LS, Rolka DB, Narayan KMV. Estimated number of adults with prediabetes in the US in 2000: opportunities for prevention. Diabetes Care 2003;26(3):645-9.
32. Melnik TA, Hosler AS, Sekhobo JP, Dufy TP, Terney EF, Engelgau MM, et al. Diabetes prevalence among adult New York City Puerto Ricans, 2000. Am J Public Health 2004;94(3):434-7.
33. Whitford DL, Lamont SS, Crosland A. Screening for type 2 diabetes: is it worthwhile? View of general practitioners and practice nurses. Diabetes Med 2003;20(2):155-8.
34. Williams R, Rapport F, Elwyn G, Lloyd B, Rance J, Belcher S. The prevention of type 2 diabetes: general practitioner and practice nurse opinions. Br J Gen Pract 2004;54(504):531-5.
35. Evans PH, Greaves C, Winder R, Fearn-Smith J, Campbell JL. Development of an educational "toolkit" for health professionals and their patients with prediabetes: the WAKEUP study (Ways of Addressing Knowledge Education and Understanding in Pre-diabetes). Diabetic Med 2007;24(7):770-77.